文献速递肺外科

社区社会经济劣势与早期非小细胞肺癌微创切除术使用的关联

Association of neighborhood socioeconomic disadvantage with use of minimally invasive resection for non-small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-12-14

该研究基于2010—2020年美国国家癌症数据库,纳入217762例I期非小细胞肺癌接受肺叶/亚肺叶切除的成人患者,其中112304例(52%)接受微创切除。微创比例从2010年27%升至2020年72%(P < .001)。调整后,较低社区收入中位数和社区医院就诊与接受微创切除的 odds 降低独立相关;在高微创手术量中心,最低收入与2010—2015年微创切除可能性降低相关,但后期该关联不再显著。作者认为存在基于社区收入的差异,需创新干预以扩大高手术量微创中心的可及性并确保公平可及。

要点

  • 2010—2020年I期非小细胞肺癌微创切除比例从27%升至72%(P < .001)。
  • 较低社区收入中位数与微创切除 odds 降低独立相关,最低四分位 adjusted OR 0.78(95% CI 0.75-0.81)。
  • 社区医院就诊与微创切除 odds 降低独立相关(adjusted OR 0.70,95% CI 0.68-0.71)。

核心结论

  • 本研究识别出基于社区收入的显著差异,影响患者接受微创切除作为确定性手术治疗的可能性;作者认为需要新颖干预措施以扩大高手术量微创切除中心的可及性并确保微创手术的公平可及。

研究设计与样本

  • 使用2010—2020年美国国家癌症数据库,纳入所有接受肺叶/亚肺叶切除的I期非小细胞肺癌成人患者,共217762例,其中112304例(52%)接受微创切除(胸腔镜/机器人),其余为开放手术;医院按微创切除手术量分层,最高四分位定义为高微创切除手术量中心;构建多变量模型评估患者、疾病和医院因素与接受微创切除可能性的独立关联。

主要发现

  • 微创切除比例从2010年27%上升至2020年72%(P < .001)。
  • 调整后,与收入最高四分位(76th-100th百分位)相比,社区收入中位数较低四分位的微创切除 odds 降低:51st-75th百分位 adjusted OR 0.92(95% CI 0.89-0.94),26th-50th百分位 adjusted OR 0.86(95% CI 0.83-0.89),0-25th百分位 adjusted OR 0.78(95% CI 0.75-0.81)。
  • 与学术中心相比,社区医院就诊与微创切除 odds 降低独立相关(adjusted OR 0.70,95% CI 0.68-0.71)。
  • 在高微创切除手术量中心接受治疗的患者中,最低收入与2010—2015年接受微创切除可能性降低相关(adjusted OR 0.85,95% CI 0.77-0.94;参照最高收入),但在后期年份未改变微创切除 odds(adjusted OR 1.01,95% CI 0.87-1.16;参照最高收入)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Minimally invasive resection for non-small cell lung cancer has been linked to decreased postoperative morbidity. This work sought to characterize factors associated with receiving minimally invasive surgery for surgically resectable non-small cell lung cancer. METHODS: All adults undergoing lobectomy/sublobar resection for stage I non-small cell lung cancer were identified using the 2010-2020 National Cancer Database. Those undergoing thoracoscopic/robotic procedures comprised the minimally invasive resection cohort (others: open). Hospitals were stratified by minimally invasive resection procedure volume, with the top quartile considered high minimally invasive resection volume centers. Multivariable models were constructed to assess the independent association between the patients, diseases, and hospital factors and the likelihood of receiving minimally invasive resection. RESULTS: Of 217,762 patients, 112,304 (52%) underwent minimally invasive resection. The proportion of minimally invasive resection procedures increased from 27% in 2010 to 72% in 2020 (P < .001). After adjustment, several factors were independently associated with decreased odds of receiving minimally invasive resection, including lower quartiles of median neighborhood income (51st-75th percentile adjusted odds ratio, 0.92, 95% CI, 0.89-0.94; 26th-50th percentile adjusted odds ratio, 0.86, CI, 0.83-0.89; 0-25th percentile adjusted odds ratio, 0.78, CI, 0.75-0.81; reference: 76th-100th percentile income) and care at community hospitals (adjusted odds ratio, 0.70, CI, 0.68-0.71; reference: academic centers). Among patients receiving care at high minimally invasive resection volume centers, lowest income remained linked with reduced likelihood of undergoing minimally invasive resection from 2010 to 2015 (adjusted odds ratio, 0.85, CI, 0.77-0.94), but did not alter the odds of minimally invasive resection in later years (adjusted odds ratio, 1.01, CI, 0.87-1.16; reference: highest income). CONCLUSIONS: This study identified significant community income-based disparities in the likelihood of undergoing minimally invasive resection as definitive surgical treatment. Novel interventions are warranted to expand access to high-volume minimally invasive resection centers and ensure equitable access to minimally invasive surgery.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sakowitz S, Bakhtiyar SS, Curry J, et al. Association of neighborhood socioeconomic disadvantage with use of minimally invasive resection for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023. PMID: 38101767. doi:10.1016/j.jtcvs.2023.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。